Start here if you're new
what it is
Dow makes the plastics, chemicals, and coatings that end up in packaging, buildings, cars, and consumer goods.
how it gets paid
Last year Dow made $40.0B in revenue. Packaging & Specialty Plastics was the main engine at $14.0B, or 35% of sales.
why growth slowed
Revenue fell 7.0% last year. The 5.56% EPS beat mattered because it showed costs did not deteriorate as badly as feared.
what just happened
Dow reported EPS of -$0.34 versus a -$0.36 estimate, a small beat inside a still-weak operating backdrop.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
35/100 earnings predictability — expect surprises
6.0% dividend yield — cash in your pocket every quarter
6.5% return on capital — nothing to write home about
xvary composite: 50/100 — below average
What they do
Dow makes the plastics, chemicals, and coatings that end up in packaging, buildings, cars, and consumer goods.
Dow wins on scale and repetition. It produced $40.0B in annual revenue and serves packaging, construction, energy, and auto customers, so your toothpaste tube and your car parts can trace back to the same network. That spread helps keep plants full and costs lower, which matters in chemicals where small margin changes hit profits hard.
How they make money
$40.0B
annual revenue · their business grew -7.0% last year
Packaging & Specialty Plastics
$14.0B
Hydrocarbons & Energy
$6.0B
Industrial Solutions
$7.0B
Polyurethanes & Construction Chemicals
$5.0B
Performance Materials & Coatings
$8.0B
The products that matter
polyethylene and packaging materials
Packaging & Specialty Plastics
$14.0B · ~35% of revenue
This matches the segment table above—the largest slice of the ~$40B total. Company revenue fell ~7% last year; if Dow works from here, this line has to stabilize first.
largest segment
coatings and performance materials
Performance Materials & Coatings
$8.0B · ~20% of revenue
Second-largest named segment on this page—a clean read on industrial and construction-linked demand when end markets soften.
cycle tell
industrial and intermediate chemicals
Industrial Solutions + other segments
$7.0B + $6.0B + $5.0B · remainder of ~$40B
Rolls up Industrial Solutions, Hydrocarbons & Energy, and Polyurethanes & Construction Chemicals from the revenue breakdown so the three cards reconcile to the same ~$40B total as the table.
full picture
Key numbers
$31
18-month target
The published 18-month target is $31 versus today's $23.45. That is the recovery case in one line: about 32% upside if the cycle heals.
6.0%
dividend yield
You are getting paid to wait, but the payout sits next to projected 2026 EPS of negative $0.10.
$17.7B
long-term debt
Debt equals 51% of capital, which means the balance sheet has less room for a long downturn.
3.1%
net margin
For every $100 of sales, Dow keeps only $3.10 in profit. Thin margins make bad cycles hurt fast.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 60 / 100
- long-term debt $17.7B (51% of capital)
- net profit margin 3.1% — keeps 3 cents of every dollar in revenue
- return on equity 14% — $0.14 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in DOW 3 years ago → it's now worth $5,660.
The index would have given you $13,920.
source: institutional data · total return
What just happened
beat estimates
Dow reported EPS of -$0.34 versus a -$0.36 estimate, a small beat inside a still-weak operating backdrop.
Beat → profit came in less bad than expected → so what: the quarter cleared a low bar, not a high one. Dow's January 2026 report showed fourth-quarter sales of about $9.5B, down 9% vs. prior year, with declines across all operating segments.
$9.5B
revenue (Q)
-$0.34
eps (Q)
5.56%
eps surprise
the number that mattered
The 5.56% EPS beat mattered because it showed costs did not deteriorate as badly as feared, even with sales down 9%.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is feedstock and energy costs squeezing plastics and chemical spreads.
high
feedstock price volatility
Oil and gas are direct input costs. If those rise while selling prices stay soft, the squeeze runs straight through a business where return on capital is already only ~6.5% on the snapshot scoreboard.
With ~$40B in annual revenue on this page, spread compression matters more than small volume misses.
med
another broad demand slide
Sales were down 9% last quarter, and every major segment fell 7–9%. If packaging, construction, and industrial demand stay weak together, the dividend story gets asked to do too much.
this is a company with $17.7B of long-term debt and a stock already down from $42 to $23. Another weak volume stretch would keep pressure on both earnings and sentiment.
low
capital return masking weak economics
A 6.0% yield and a $3B buyback sound generous. They also risk becoming the entire thesis if operating results do not improve.
Income can support patience. It does not create pricing power, and it does not by itself fix a ~6.5% return on capital if the cycle stays soft.
$17.7B of long-term debt equals 51% of capital, so Dow has less room for a long margin squeeze than the 6.0% yield makes it look like.
source: institutional data · regulatory filings · risk analysis
Pay attention to
calendar
q1 2026 earnings report
expected april 23, 2026. You want to see whether sales hold above the $9.5B q4 level and whether the weakness is still broad-based.
metric
return on capital near the ~6.5% scoreboard print
That number is not heroic for a chemical major. If it drifts lower in a prolonged slump, the stock stays a yield-and-hope story.
risk
energy and feedstock prices
Dow does not control this input. You should watch it anyway, because it has a direct line to margins.
trend
buyback pace versus business trend
A $3B authorization is only helpful if the operating trend stops sliding. If repurchases rise while sales keep falling, management is treating the symptom.
Analyst rankings
short-term outlook
below average
momentum score 4 — in human-speak, analysts think this stock has more drag than lift right now.
risk profile
average
stability score 3 — this is not a bunker stock, but it is not the wildest thing in materials either.
chart momentum
below average
technical score 4 — price action says the market still wants proof, not promises.
earnings predictability
35 / 100
earnings predictability is low. For you, that means quarterly numbers are more likely to surprise than reassure.
source: institutional data
Institutional activity
institutions have been net selling for 3 consecutive quarters — 404 buyers vs. 667 sellers in 3q2025. total institutional holdings: 0.5B shares. net selling for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$18
$43
$23
current price
$31
target midpoint · +32% from current · 3-5yr high: $40 (+70% · 20% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive